Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages. - Li, Ling; Chen, Xixian; Wang, Zuowei; Li, Yunjian; Wang, Chen; Jiang, Liwei; Zuo, Teng (PLoS Pathogens, 2023)